Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People scheduled for a non-urgent heart operation, where at least 24 hours pass between the decision to operate and the actual surgery — specifically procedures involving coronary artery bypass grafting, aortic valve replacement, aortic surgery (without stopping blood circulation), or any combination of these
- People who are able to provide written consent to participate
Who may not be able to join:
- People who have a history of atrial fibrillation (an irregular heart rhythm) or atrial flutter (a related heart rhythm problem)
- People who have previously had a heart rhythm procedure or taken medication to treat a heart rhythm problem (other than atrial fibrillation)
- People who are planned to receive, or have received, the drug amiodarone before or after surgery to prevent heart rhythm problems
- People who have a pacemaker, defibrillator (ICD), or cardiac resynchronisation device (CRT) that does not have a working lead connected to the upper chambers of the heart
- People whose aortic surgery involves cooling the body and temporarily stopping blood circulation (hypothermic circulatory arrest)
- People who have previously had heart surgery
- People who have previously had radiation treatment to the chest area for cancer
- People who have an active infection at the time of surgery
- People currently taking medications that suppress the immune system, including steroid tablets taken by mouth
- People already participating in another interventional clinical trial
- People whose home address is in another country, which would make it difficult for the trial team to follow up with them after they leave hospital
- People who do not understand the study information provided in the local language, or who the investigators consider unsuitable to participate for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Igor Zindovic Zindovic, MD, PhD, Region Skane
Phone: +4646175288
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of patients with POAF the first 7 postoperative days
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.